Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/29768152
Conclusion of this study
Among children and adults with the Lennox-Gastaut syndrome, the addition of cannabidiol at a dose of 10 mg or 20 mg per kilogram per day to a conventional antiepileptic regimen resulted in greater reductions in the frequency of drop seizures than placebo. Adverse events with cannabidiol included elevated liver aminotransferase concentrations. (Funded by GW Pharmaceuticals; GWPCARE3 ClinicalTrials.gov number, NCT02224560 .).
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study